Employers can support their team members by providing access to employee assistance programs (EAPs). This resource helps ...

Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...

More than 10,000 Victorian apprentices completed their training in 2025 and are now job-ready with in-demand skills, thanks to the Allan Labor ...

NPC is an ultra-rare, relentlessly progressive, genetic disorder that leads to premature mortality. MIPLYFFA, used in conjunction with miglustat, is the only treatment shown to halt disease ...

The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...

While the investigation into the death of Dr. Cletus Iwuagwu continues, the recovery itself left a lasting impact on the ...

NineDot Energy(R), the leading developer of community-scale battery energy storage systems (BESS) in the New York City metro area, today announced its participation in the New York Statewide Solar for ...

Happy New Year to all. My simple request in a Dec. 5 Finger Lakes Times Letter to the Editor (“FLT could use a regular ...

Spring Health reports absenteeism is rising, costing employers significantly. To combat this, tracking absences and enhancing ...

The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...

WASHINGTON — U.S. diplomats on Monday stressed Washington's focus on aligning foreign assistance with President Donald Trump's policy priorities, saying that it should be a "force multiplier" to ...

We’ll explore what burnout looks like for loan officer mental health and how it can be prevented through lifestyle shifts, ...